Radiolife

Radiolife is developing Cube Scan, a patented, reagent-free platform designed to combine radio frequency and AI to identify biological and chemical signatures in liquid samples within seconds. The company recently completed a BARDA-funded study involving arboviruses with over 95% accuracy and secured a USDA award to advance rapid avian-influenza detection, bringing fast, accessible diagnostics closer to real-world deployment.